Due to the differences in TBX21 mRNA expression between patients and controls and to achieve a more precise view of the potential impacts influenced by rs17244587 and rs41515744 polymorphisms in TBX21 expression in AD patients, we performed in silico subanalysis for additional investigation of the aforementioned polymorphisms. This evidence concerns the gene TBX21 and Alzheimer disease.